other material
confidence high
sentiment neutral
materiality 0.60
AN2 Therapeutics exchanges 2.8M common shares for pre-funded warrants with Coastlands Capital
AN2 Therapeutics, Inc.
- Exchanged 2,500,000 shares of common stock for pre-funded warrant for 2,500,000 shares on June 17, 2025.
- Exchanged additional 300,000 shares for pre-funded warrant for 300,000 shares on June 19, 2025.
- Warrants have $0.00001 exercise price, no expiration, and beneficial ownership blocker at 9.99% (up to 19.99%).
- Issued under Section 3(a)(9) exemption from registration; form of warrant filed as Exhibit 4.1.